Genotoxic and embryotoxic effects of 5-bromodeoxyuridine in the chick embryo.
Chick embryos were exposed intra-amniotically to the thymidine analog bromodeoxyuridine (BrdU) in order to study its embryotoxic and genotoxic effects. Teratogenic effects were observed at doses of BrdU which failed to produce mitotic inhibition, clastogenic effects or any significant increase in sister chromatid exchanges. Clastogenic effects and depressed cell proliferation were observed only at high embryolethal doses. Thus, BrdU-induced teratogenicity was independent of genotoxic effects manifested at chromosomal level. On the contrary, a significant increase of DNA single strand breaks was detected even 24 hours after the administration of teratogenic dose. BrdU incorporation in the DNA does not appear to prevent embryonic cells from mitotic proliferation. Whether the single strand breaks in DNA would ultimately lead to BrdU-induced teratogenesis in chick embryos remained undetermined.
Novotná
B
B
Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague.
Hubálek
F
F
Bednár
V
V
D000014:Abnormalities, Drug-Induced; D000818:Animals; D001973:Bromodeoxyuridine / Q000633:toxicity*; D002642:Chick Embryo; D002869:Chromosome Aberrations; D004247:DNA / Q000187:drug effects; D004249:DNA Damage; D004305:Dose-Response Relationship, Drug; D009153:Mutagens / Q000633:toxicity*; D012854:Sister Chromatid Exchange / Q000187:drug effects
D009153:Mutagens; D004247:DNA; D001973:Bromodeoxyuridine